| Application no. and date | 17823190.8 (espacenet) (Federated) (European Patent Register), 20171221 | | Patent/reg. no. and date | DK/EP 3478719, 20210120 | | Publication date | 20190508 | | Priority no. and date | US 201662437353 P, 20161221 | | EP pub. no. and date |
EP 3478719 20190508 | | Effective date | | | Applicant/owner | Mereo Biopharma 3 Limited, 4th Floor 1 Cavendish Place
London W1G 0QF, GB | | Applicant ref. no. | P75473DK01 | | Inventor | KNEISSEL, Michaela, c/o Novartis Pharma AG
Postfach
4002 Basel, CH,
HALL, Anthony Kent, Prins Hendriklaan 16
2341 JB Oegstgeest, NL,
EUDY, Rena Joy, 25 Lawler Road
West Hartford
Connecticut 06117, US,
RIGGS, Matthew Manning, 1189 Saybrook Road
Haddam
Connecticut 06438, US,
JUNKER, Uwe, c/o Roche Innovation Center
Grenzacherstrasse 124
Building 68 / Room 217
4070 Basel, CH | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61K 39/395 (2006.01) , A61P 19/08 (2006.01) , C07K 16/22 (2006.01) | | Title | ANVENDELSE AF ANTI-SCLEROSTIN-ANTISTOFFER I BEHANDLINGEN AF OSTEOGENESIS IMPERFECTA | | Int. application no. | GB2017053850 | | Int. publication no. | WO2018115880 | | Related patent (certificate) | | | Status | DK/EP patent med begrænsede krav | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
